Updated:
FiTalent
FiTalent is the corporate venture capital fund of everis Group. It invests in technology companies with proven success, focusing on human assets.
FiTalent
FiTalent is the corporate venture capital fund of everis Group. It invests in technology companies with proven success, focusing on human assets. FiTalent has made 18 investments, including a Series B investment in Ability Pharma on March 11, 2024.
General information
Firm type
Private Equity
Year founded
2011
Location
Region
Europe
Country
Spain
City
Madrid
Corporate office
Madrid, Spain
Sector focus
Frequently asked questions
Where does FiTalent's capital come from?
The source of FiTalent's investment capital is not publicly disclosed. The firm has not identified whether it operates as a proprietary capital vehicle, a traditional closed-end fund with external limited partners, or a hybrid structure. This opacity is common among sub-scale managers in Southern Europe that have not yet raised institutional capital requiring public disclosure.
What is FiTalent's known posture on co-investments alongside external GPs?
There is no public record of FiTalent participating in co-investment syndicates or partnering with external general partners in disclosed rounds. Without named portfolio companies or deal announcements, the firm's co-investment appetite and track record remain unobservable to external analysts and peer investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: